PORTLAND, GA, UNITED STATES, November 5, 2024 /EINPresswire / -- The global Implantable Insulin Pump Market was pegged at $2.67 billion in 2020, and is estimated to reach $6.44 billion by 2030, ...

CVS expects elevated medical costs to continue to pressure its performance this year, “and as a result we are not providing a ...

This story was originally published by KFF Health News. While customers at Adams Family Pharmacy picked up their ...

CVS Health reported mixed third-quarter results ... FTC sues drug middlemen for allegedly inflating insulin prices Pfizer says drug for deadly cancer condition that causes weight loss shows ...

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

Drug coupon aggregator GoodRx and pharmacy benefit managers including CVS Caremark and Express Scripts have been hit with at least three class action lawsuits accusing them of working together to ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

The other, the Federal Trade Commission, is already conducting a major investigation of pharmacy benefit managers and is ...

Independent advisers to the FDA voted against recommending Lexicon Pharmaceuticals‘ add-on treatment to insulin therapy for ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...